HomeOpen Access NewsDrug Development

Drug Development

Microbes transform plastic waste into paracetamol

A new study has found that a common bacterium can turn everyday plastic waste into paracetamol.

England becomes first to offer belantamab mafodotin for multiple myeloma  

Around 1,500 people in England with multiple myeloma will benefit from belantamab mafodotin, used in combination with bortezomib and dexamethasone.

New drug combination offers hope for alcohol use disorder treatment

A recent study from the University of Gothenburg has discovered that two existing medications can effectively treat alcohol use disorder, reducing both alcohol consumption and cravings.

UK strives to become a global leader in AI-driven drug discovery

The UK Government is pushing itself to become a world leader in AI-powered drug discovery with new investments and global partnerships announced during London's Tech Week.

‘AI scientist’ finds common drug combinations can kill breast cancer cells

An 'AI scientist', working in collaboration with human scientists, has discovered that combinations of cheap and safe drugs could be effective at treating breast cancer.

Backed by the UN, governments are breaking down antimicrobial resistance

Jacqueline Alvarez, Chief of the Chemicals and Health Branch at the UN Environment Programme (UNEP), explores the importance of holistic, One Health efforts to mitigate the growing threat of antimicrobial resistance.

Rethinking responsibility: A collaborative approach to medication safety

Most medication errors are preventable with the right conditions. Successful technology implementation requires careful planning, proper training, and a commitment to system-wide improvements, as explained by Stéphane Boulanger, Policy Advisor at the European Patient Safety Foundation (EUPSF).

First significant ischemic stroke therapy advancement since 2002

A new study by the University of Manchester has found that a new clotbusting drug is significantly better at treating ischemic stroke than existing treatments.

$2.7 Million NIH grant fuels development of first comprehensive syphilis test

Amidst a stark rise in US syphilis cases, researchers have secured a $2.7 million NIH grant to develop the first comprehensive, rapid test for active infection that aims to deliver accurate results within 10 minutes.

UKHSA reports rising resistance to newest antibiotics on NHS

A new study shows some bacteria have already become resistant to one of the latest antibiotics available on the NHS.

The impact of cannabis use during pregnancy

With areas of expertise in cannabis use and brain disorders, Justine Renard from the Canadian Centre on Substance Use and Addiction spoke to Lorna Rothery about the prevalence and potential impacts of cannabis use during pregnancy.

UHCW to lead trial of new device to address miscarriage symptoms

University Hospitals Coventry and Warwickshire (UHCW) NHS Trust is to lead a clinical trial of a novel device aimed at addressing miscarriage symptoms.

Over 3 Million children died from AMR-related infections in 2022

A landmark study presented at ESCMID Global 2025 reveals the devastating impact of antimicrobial resistance (AMR) on children's health. In 2022, over 3 million children worldwide died from antibiotic-resistant infections, highlighting the urgent need for global action.

First-ever NHS treatment approved for advanced Hodgkin lymphoma

New combination therapy will be available on the NHS, offering new hope to people with advanced Hodgkin lymphoma.

New drug delivery systems for long lasting treatments with fewer injections

MIT engineers have developed a new drug delivery method that could change long-term treatments with fewer injections and less discomfort.

iDOMO: New AI tool predicts synergistic drug combinations

Researchers at Mount Sinai have developed iDOMO, a powerful AI tool that predicts synergistic drug combinations for complex diseases like cancer.

Nenolizumab has recently been approved for two chronic skin conditions

A new medicine, Nenolizumab, has been approved by the Medicines and Healthcare Products Regulatory Agency (MHRA) to treat two skin conditions

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders